NCT01103765

Brief Summary

Comparison with use of Intravascular Ultrasound (IVUS) analysis of two methods of percutaneous coronary interventions (PCI) with drug eluting stent: After successful drug eluting stent implantation, patients were randomized into two groups: Group A had no further dilatation, and Group B had additional post-dilatation with a noncompliant balloon. The investigators performed IVUS analysis in groups A and B just before randomization and after post-dilatation in group B.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
220

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Apr 2010

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

April 13, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 15, 2010

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2011

Completed
Last Updated

June 16, 2011

Status Verified

June 1, 2011

Enrollment Period

1.6 years

First QC Date

April 13, 2010

Last Update Submit

June 14, 2011

Conditions

Keywords

Post-dilatationnoncompliant balloonoptimal stent deployment of drug-eluting stentIntravascular ultrasound (IVUS)Optimal stent deployment defined by intravascular ultrasound analysis

Outcome Measures

Primary Outcomes (1)

  • Optimal stent deployment defined by IVUS analysis

    The primary endpoint is optimum stent deployment. For defining the optimal stent deployment we use the IVUS criteria adopted in the MUSIC study: Complete apposition without underexpansion and with symmetric stent expansion. All patients(group A and B) will have IVUS analysis for defining optimal stent deployment

    at 18 months

Secondary Outcomes (1)

  • Complications of percutaneous coronary intervention (PCI)

    at day0, at day1, at the end of hospitalisation and year1

Study Arms (2)

classic strategy

PLACEBO COMPARATOR

after drug-eluting stent(DES) deployment perform of Intravascular ultrasound analysis without post-dilatation

Procedure: stent deployment without post-dilatation

post-dilatation strategy

ACTIVE COMPARATOR

After drug-eluting stent (DES) deployment IVUS analysis and systematic post-dilatation with noncompliant balloon 0.25mm larger than stent balloon. After post dilatation new IVUS analysis.

Procedure: post dilatation after stent deployment

Interventions

Post-dilatation with a noncompliant balloon larger 0.25mm than stent balloon.

post-dilatation strategy

stent deployment without systematic post dilatation

classic strategy

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Successful drug eluting stent implantation in a native coronary artery

You may not qualify if:

  • Percutaneous coronary intervention (PCI) of Left main coronary artery;
  • Myocardial infarction;
  • Acute coronary syndrome;
  • Emergency PCI;
  • PCI for in-stent restenosis;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de cardiologie interventionnelle - Hôpital Lariboisière

Paris, 75010, France

RECRUITING

Study Officials

  • Georgios SIDERIS, MD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NETWORK

Study Record Dates

First Submitted

April 13, 2010

First Posted

April 15, 2010

Study Start

April 1, 2010

Primary Completion

November 1, 2011

Study Completion

November 1, 2011

Last Updated

June 16, 2011

Record last verified: 2011-06

Locations